Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to measure the effects of LGT209 when given intravenously to patients
with high cholesterol who are on stable doses of statin medications, and to healthy subjects
with elevated cholesterol